Quercetin protects cardiomyocytes against doxorubicin-induced toxicity by suppressing oxidative stress and improving mitochondrial function via 14-3-3γ

References

• Abdel-Daim MM, Kilany OE, Khalifa HA, Ahmed AAM. 2017. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Cancer Chemother Pharmacol. 80:745–753.
   PubMed Web of Science ®Google Scholar
• Abushouk AI, Ismail A, Salem AMA, Afifi AM, Abdel-Daim MM. 2017. Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomed Pharmacother. 90:935–946.
   PubMed Web of Science ®Google Scholar
• Aitken A. 2006. 14-3-3 proteins: a historic overview. Semin Cancer Biol. 16:162–172.
   PubMed Web of Science ®Google Scholar
• Akolkar G, da Silva Dias D, Ayyappan P, Bagchi AK, Jassal DS, Salemi VMC, Irigoyen MC, De Angelis K, Singal PK. 2017. Vitamin C mitigates oxidative/nitrosative stress and inflammation in doxorubicin-induced cardiomyopathy. Am J Physiol Heart Circulatory Physiol. 313:H795–H809.
   PubMed Web of Science ®Google Scholar
• Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. 2010. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 102:14–25.
   PubMed Web of Science ®Google Scholar
• Allouis M, Le Bouffant F, Wilders R, Péroz D, Schott JJ, Noireaud J, Le Marec H, Mérot J, Escande D, Baró I. 2006. 14-3-3 is a regulator of the cardiac voltage-gated sodium channel Nav1.5. Circ Res. 98:1538–1546.
   PubMed Web of Science ®Google Scholar
• al-Shabanah OA, Badary OA, Nagi MN, al-Gharably NM, al-Rikabi AC, al-Bekairi AM. 1998. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J Exp Clin Cancer Res. 17:193–198.
   PubMed Web of Science ®Google Scholar
• Anand David AV, Arulmoli R, Parasuraman S. 2016. Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev. 10:84–89.
   PubMedGoogle Scholar
• Andres S, Pevny S, Ziegenhagen R, Bakhiya N, Schäfer B, Hirsch-Ernst KI, Lampen A. 2018. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 62. doi:10.1002/mnfr.201700447.
   PubMed Web of Science ®Google Scholar
• Angsutararux P, Luanpitpong S, Issaragrisil S. 2015. Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress. Oxid Med Cell Longev. 2015:795602.
   PubMed Web of Science ®Google Scholar
• Barteková M, Šimončíková P, Fogarassyová M, Ivanová M, Okruhlicová Ľ, Tribulová N, Dovinová I, Barančík M. 2015. Quercetin improves postischemic recovery of heart function in doxorubicin-treated rats and prevents doxorubicin-induced matrix metalloproteinase-2 activation and apoptosis induction. Int J Mol Sci. 16:8168–8185.
   PubMed Web of Science ®Google Scholar
• Bishop S, Liu SJ. 2017. Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin. Phytomedicine. 36:210–216.
   PubMed Web of Science ®Google Scholar
• Brady NR, Elmore SP, van Beek JJ, Krab K, Courtoy PJ, Hue L, Westerhoff HV. 2004. Coordinated behavior of mitochondria in both space and time: a reactive oxygen species-activated wave of mitochondrial depolarization. Biophys J. 87:2022–2034.
   PubMed Web of Science ®Google Scholar
• Brady NR, Hamacher-Brady A, Westerhoff HV, Gottlieb RA. 2006. A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxid Redox Signal. 8:1651–1665.
   PubMed Web of Science ®Google Scholar
• Cappetta D, De Angelis A, Sapio L, Prezioso L, Illiano M, Quaini F, Rossi F, Berrino L, Naviglio S, Urbanek K. 2017. Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardio-toxicity. Oxid Med Cell Longevity. 2017:1.
   Google Scholar
• Cappetta D, Rossi F, Piegari E, Quaini F, Berrino L, Urbanek K, De Angelis A. 2018. Doxorubicin targets multiple players: a new view of an old problem. Pharmacol Res. 127:4–14.
   PubMed Web of Science ®Google Scholar
• Chen HP, He M, Xu YL, Huang QR, Zeng GH, Liu D, Liao ZP. 2007. Anoxic preconditioning up-regulates 14-3-3 protein expression in neonatal rat cardiomyocytes through extracellular signal-regulated protein kinase 1/2. Life Sci. 81:372–379.
   PubMed Web of Science ®Google Scholar
• Coelho AR, Martins TR, Couto R, Deus C, Pereira CV, Simões RF, Rizvanov AA, Silva F, Cunha-Oliveira T, Oliveira PJ, et al. 2017. Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts. Biochim Biophys Acta.1863:2904–2923.
   PubMed Web of Science ®Google Scholar
• Cote B, Carlson LJ, Rao DA, Alani AWG. 2015. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. J Control Release. 213:128–133.
   PubMed Web of Science ®Google Scholar
• D’Andrea G. 2015. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia. 106:256–271.
   PubMed Web of Science ®Google Scholar
• Denel-Bobrowska M, Marczak A. 2017. Structural modifications in the sugar moiety as a key to improving the anticancer effectiveness of doxorubicin. Life Sci. 178:1–8.
   PubMed Web of Science ®Google Scholar
• Dong Q, Chen L, Lu Q, Sharma S, Li L, Morimoto S, Wang G. 2014. Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression. Br J Pharmacol. 171:4440–4454.
   PubMed Web of Science ®Google Scholar
• Eid HM, Haddad PS. 2017. The antidiabetic potential of quercetin: underlying mechanisms. Curr Med Chem. 24:355–364.
   PubMed Web of Science ®Google Scholar
• Enns GM, Cowan TM. 2017. Glutathione as a redox biomarker in mitochondrial disease-implications for therapy. J Clin Med. 6:pii:E50.
   PubMed Web of Science ®Google Scholar
• Fan J, Xu G, Nagel DJ, Hua Z, Zhang N, Yin G. 2010. A model of ischemia and reperfusion increases JNK activity, inhibits the association of BAD and 14-3-3, and induces apoptosis of rabbit spinal neurocytes. Neurosci Lett. 473:196–201.
   PubMed Web of Science ®Google Scholar
• Fu H, Subramanian RR, Masters SC. 2000. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol. 40:617–647.
   PubMed Web of Science ®Google Scholar
• Gabizon AA, Patil Y, La-Beck NM. 2016. New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy. Drug Resist Updat. 29:90–106.
   PubMed Web of Science ®Google Scholar
• Ghigo A, Li M, Hirsch E. 2016. New signal transduction paradigms in anthracycline-induced cardiotoxicity. Biochim Biophys Acta. 1863:1916–1925.
   PubMed Web of Science ®Google Scholar
• Guo X, Chen M, Zeng H, Liu P, Zhu X, Zhou F, Liu J, Zhang J, Dong Z, Tang Y, et al. 2018. Quercetin attenuates ethanol-induced iron uptake and myocardial injury by regulating the angiotensin II-L-type calcium channel. Mol Nutr Food Res. 62. doi:10.1002/mnfr.201700772.
   Web of Science ®Google Scholar
• He H, Luo Y, Qiao Y, Zhang Z, Yin D, Yao J, You J, He M. 2018. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ. Food Funct. 9:4404–4418.
   PubMed Web of Science ®Google Scholar
• He H, Zhou Y, Huang JY, Wu ZL, Liao ZP, Liu D, Yin D, He M. 2017. Capsaicin protects cardiomyocytes against anoxia/reoxygenation injury via preventing mitochondrial dysfunction mediated by SIRT1. Oxid Med Cell Longevity. 2017:1035702.
   PubMed Web of Science ®Google Scholar
• He M, Zhang JX, Shao LJ, Huang Q, Chen J, Chen H, Chen X, Liu D, Luo Z. 2006. Up-regulation of 14-3-3 isoforms in acute rat myocardial injuries induced by burns and lipopolysaccharide. Clin Exp Pharmacol Physiol. 33:374–380.
   PubMed Web of Science ®Google Scholar
• Huang J, Liu Z, Xu P, Zhang Z, Yin D, Liu J, He H, He M. 2018. Capsaicin prevents mitochondrial damage, protects cardiomyocytes subjected to anoxia/reoxygenation injury mediated by 14-3-3η/Bcl-2. Eur J Pharmacol. 819:43–50.
   PubMed Web of Science ®Google Scholar
• Jain AK, Mehra NK, Swarnakar NK. 2015. Role of antioxidants for the treatment of cardiovascular diseases: challenges and opportunities. Curr Pharm Des. 21:4441–4455.
   PubMed Web of Science ®Google Scholar
• Johnson R, Shabalala S, Louw J, Kappo AP, Muller CJF. 2017. Aspalathin reverts doxorubicin-induced cardiotoxicity through increased autophagy and decreased expression of p53/mTOR/p62 signaling. Molecules. 22:pii:1589.
   Web of Science ®Google Scholar
• Khan F, Niaz K, Maqbool F, Ismail Hassan F, Abdollahi M, Nagulapalli Venkata KC, Nabavi SM, Bishayee A. 2016. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients. 8:pii:529.
   PubMed Web of Science ®Google Scholar
• Khedr NF, Khalil RM. 2015. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin. Tumour Biol. 36:9267–9275.
   PubMedGoogle Scholar
• Kilbride SM, Prehn JH. 2013. Central roles of apoptotic proteins in mitochondrial function. Oncogene. 32:2703–2711.
   PubMed Web of Science ®Google Scholar
• Kontoghiorghe CN, Kolnagou A, Kontoghiorghes GJ. 2014. Antioxidant targeting by deferiprone in diseases related to oxidative damage. Front Biosci. 19:862–885.
   PubMed Web of Science ®Google Scholar
• Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y. 2016. Quercetin, inflammation and immunity. Nutrients. 8:167.
   PubMed Web of Science ®Google Scholar
• Liu D, Yi B, Liao Z, Tang L, Yin D, Zeng S, Yao J, He M. 2014. 14-3-3γ protein attenuates lipopolysaccharide-induced cardiomyocytes injury through the Bcl-2 family/mitochondria pathway. Int Immunopharmacol. 21:509–515.
   PubMed Web of Science ®Google Scholar
• Lynn EG, McLeod CJ, Gordon JP, Bao J, Sack MN. 2008. SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells. FEBS Lett. 582:2857–2862.
   PubMed Web of Science ®Google Scholar
• Massi A, Bortolini O, Ragno D, Bernardi T, Sacchetti G, Tacchini M, De Risi C. 2017. Research progress in the modification of quercetin leading to anticancer agents. Molecules. 22:pii:1270.
   PubMed Web of Science ®Google Scholar
• Montaigne D, Marechal X, Baccouch R, Modine T, Preau S, Zannis K, Marchetti P, Lancel S, Neviere R. 2010. Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart. Toxicol Appl Pharmacol. 244:300–307.
   PubMed Web of Science ®Google Scholar
• Ojha S, Al Taee H, Goyal S, Mahajan UB, Patil CR, Arya DS, Rajesh M. 2016. Cardioprotective potentials of plant-derived small molecules against doxorubicin associated cardiotoxicity. Oxid Med Cell Longevity. 2016:1.
   Web of Science ®Google Scholar
• Pozuelo-Rubio M. 2010. Proteomic and biochemical analysis of 14-3-3-binding proteins during C2-ceramide-induced apoptosis. FEBS J. 277:3321–3342.
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Barton M. 2014. Estrogen biology: new insights into GPER function and clinical opportunities. Mol Cell Endocrinol. 389:71–83.
   PubMed Web of Science ®Google Scholar
• Renu K, V.G A, P.B TP, Arunachalam S. 2018. Molecular mechanism of doxorubicin-induced cardiomyopathy-an update. Eur J Pharmacol. 818:241–253.
   PubMed Web of Science ®Google Scholar
• Rochette L, Guenancia C, Gudjoncik A, Hachet O, Zeller M, Cottin Y, Vergely C. 2015. Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. Trends Pharmacol Sci. 36:326–348.
   PubMed Web of Science ®Google Scholar
• Tang L, Peng Y, Xu T, Yi X, Liu Y, Luo Y, Yin D, He M. 2013. The effects of quercetin protect cardiomyocytes from A/R injury is related to its capability to increasing expression and activity of PKCε protein. Mol Cell Biochem. 382:145–152.
   PubMed Web of Science ®Google Scholar
• van der Woude H, Ter Veld MG, Jacobs N, van der Saag PT, Murk AJ, Rietjens IM. 2005. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. Mol Nutr Food Res. 49:763–771.
   PubMed Web of Science ®Google Scholar
• van Hemert MJ, Steensma HY, van Heusden GP. 2001. 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays. 23:936–946.
   PubMed Web of Science ®Google Scholar
• Varga ZV, Ferdinandy P, Liaudet L, Pacher P. 2015. Drug-induced mitochondrial dysfunction and cardiotoxicity. Am J Physiol Heart Circ Physiol. 309:H1453–H1467.
   PubMed Web of Science ®Google Scholar
• Xu F, Li X, Xiao X, Liu LF, Zhang L, Lin PP, Zhang SL, Li QS. 2017. Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity. Biomed Pharmacother. 95:504–512.
   PubMed Web of Science ®Google Scholar
• Zakaria N, Khalil SR, Awad A, Khairy GM. 2018. Quercetin reverses altered energy metabolism in the heart of rats receiving adriamycin chemotherapy. Cardiovasc Toxicol. 18:109–119.
   PubMed Web of Science ®Google Scholar
• Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. 2000. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 192:1001–1014.
   PubMed Web of Science ®Google Scholar
• Zorov DB, Juhaszova M, Sollott SJ. 2006. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta. 1757:509–517.
   PubMed Web of Science ®Google Scholar